期刊文献+

消渴化瘀片对糖尿病大鼠糖脂代谢的影响 被引量:1

Effect of xiaokehuayu pills on blood glucose and lipid in diabetic rats
下载PDF
导出
摘要 目的观察中药消渴化瘀片对实验性2型糖尿病(T2DM)合并高血脂大鼠血糖、血脂代谢的影响。方法60只健康Wistar大鼠,随机分为6组:正常大鼠对照组、模型组、小剂量消渴化瘀片组、中剂量消渴化瘀片组、大剂量消渴化瘀片组、玉泉丸组;采用高脂饮食和四氧嘧啶(aLLoxan)腹腔注射建立糖尿病大鼠模型。比较各组治疗后空腹血糖(FPG)、餐后2h血糖(P2hPG)、空腹胰岛素(FIns)、餐后2h胰岛素(P2hIns)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平。结果实验性糖尿病大鼠模型组FPG、P2hPG、FIns、P2hIns、TG、TC、HDL-C、LDL-C等指标明显高于正常对照组,P<0.05。经中药消渴化瘀片、玉泉丸治疗6周后,消渴化瘀片大剂量组P2hPG10.34±2.88mmol/L、FIns28.66±5.56U/L、P2hIns35.52±14.79U/L,TG1.62±0.19mmol/L、LDL-C2.34±1.07mmol/L水平显著下降,与模型组P2hPG15.91±2.64mmol/L、FIns48.73±19.29U/L、P2hIns66.72±26.09U/L、TG2.98±0.23mmol/L、LDL-C4.59±0.86mmol/L比较P<0.05;玉泉丸组FIns26.33±9.60U/L、P2hIns37.40±12.45U/L水平显著下降,与模型组比较P<0.05。结论中药消渴化瘀片能降低实验性T2DM大鼠P2hPG、FIns、P2hIns、TG、LDL-C水平,且调脂作用优于玉泉丸。 Objective To evaluate effects of xiaokehuayu pill on diabetic hyperlipidemia (HLP)rats. Methods Diabetic mellitus (DM)rat model was induced by injection of Alloxan with rich lipid food. 60 rats were divided into 6 groups :normal control group, DM group, high/middle/low dose group of xiaokehuayu pills and yuquan pills group. The treatment last for 6 weeks with xiaokehuayu pills and yuquan pills. The blood glucose and TG ,TC, HDL, LDL were messured before and after treatment. Results The FPG ,P2hPG and Fins ,P2hlns ,TG ,T C, HDL-C, LDL-C in experimental DM rats were significantly higher than normal control group ,P〈0.05. High dose of xiaokehuayu pills significantly reduced P2hPG 10.34 ± 2.88 mmol/L,Flns 28.66±5.56 U/L,P2hIns 35.52±14.79 U/L,TG 1.62±0.19 mmol/L,LDL-C 2.34±1.07 mmol/L compared with model group 15.91±2.64 mmol/L,48.73±19.29 U/L,66.72±26.09 U/L,2.98±0.23 mmol/L,4.59±0.86 mmol/L respectively, P〈0.05. Yuquan pills group significantly reduced 26.33± 9.60 U/L,P2hIns 37.40±12.45 U/L,compared with model group P〈0.05. Conclusions Xiaokehuayu pills reduced blood glucose concentration and high lipid level in DM rats. The multiple effects of xiaokehuayu pills are considerable;the effect intensified as dosage of xiaokehuayu pills increased.
出处 《中华保健医学杂志》 2008年第4期284-286,共3页 Chinese Journal of Health Care and Medicine
基金 解放军总医院新药研发基金课题资助项目(01EC06)
关键词 糖尿病 高脂血症 中药治疗 消渴化瘀片 Diabetes millitus Hyperlipemia Therapy of CMM Xiaokehuayu pills
  • 相关文献

参考文献8

二级参考文献43

  • 1王开富,李鸣真,叶望云,柳重威,龚波.四氧嘧啶剂量和家兔性别对制作糖尿病模型的影响[J].同济医科大学学报,1994,23(3):223-225. 被引量:14
  • 2陈利国,马民,屈援,张春玲.糖尿病血瘀证研究进展[J].中华中医药杂志,2005,20(2):114-116. 被引量:50
  • 3潘长玉,陆菊明,田慧,孔祥涛,陆小平,姚晨,蒋赐恩,邓心新,王淑玉,张效良,王正升,韩松,崔岚.首都钢铁公司成年人糖尿病患病率的调查[J].中华医学杂志,1995,75(7):409-413. 被引量:166
  • 4Executive Summary of the Third Report of the National cholesterol Education Program(NCEP) .Expert Panel on Detection, Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment PanelⅢ)[J]. JAMA,2001, 285:2486-2497.
  • 5McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[J]. Diabetes,2002,51:7-18.
  • 6Cook CB, Erdman DM, Ryan GJ,et al. The pattern of dyslipidemia among urban African-Americans with type 2 diabetes[J]. Diabetes Care, 2000,23:319-324.
  • 7Perez A, Wagner AM, Carreras G,et al. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control[J]. Arch Intern Med,2000,160:2756-2762.
  • 8李光伟 胡仁明 等.胰岛素抵抗和胰岛β细胞功能评估.内分泌代谢病临床新技术[M].北京:人民军医出版社,2002.423.
  • 9田浩明.胰岛素抵抗与血脂及脂蛋白异常的关系[J].辽宁实用糖尿病杂志,1999,(1):51-55.
  • 10王米渠 林乔 张天娥 等.肾阳虚证基因组研究的背景方法发展与前景[J].国际生物信息与中医药论丛,2004,2(2):106-118.

共引文献86

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部